Sun Pharmaceutical Industries dividend 2025

SUNPHARMA

1737

18.90 (-1.08%)
Last updated on 24 Dec, 2025 | 15:58 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Sun Pharmaceutical Industries Dividend Details

Record Date

07-Jul-2025

Dividends Date

07-Jul-2025

Ex Date

07-Jul-2025

Dividend Type

Equity Share

Dividend Per Share

550.00

The Sun Pharmaceutical Industries has declared a Equity Share dividend of 550 per share. Investors should note the record date of 07-Jul-2025, and the ex-dividend date 07-Jul-2025 to confirm eligibility for the payout. This move underscores the company’s ongoing efforts to enhance shareholder value through regular dividend distributions.

Sun Pharmaceutical Industries Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
07-Jul-20255.50Equity Share07-Jul-2025
06-Feb-202510.50Equity Share06-Feb-2025

Upcoming Dividends by Indian Companies

View More
No Data Found

Sun Pharmaceutical Industries Dividend FAQs

The latest dividend declared by Sun Pharmaceutical Industries is of 5.5 per share for the financial year as announced on 07-Jul-2025.

Registered shareholders who own Sun Pharmaceutical Industries’s shares on or before the record date of 07-Jul-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 07-Jul-2025.

You can expect to receive Sun Pharmaceutical Industries’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 07-Jul-2025. The record date is when Sun Pharmaceutical Industries identifies eligible shareholders for the dividend payment.

The annual dividend paid by Sun Pharmaceutical Industries varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Sun Pharmaceutical Industries's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.